Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer.

Won B, Mambetsariev I, Salgia R. Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer. BMC Cancer. 2016 08 02; 16:568.

View in: PubMed

collapse authors with profiles